3,189 Days: Aduhelm Phase IV Timeline Is Long Among Alzheimer’s Drugs And Other Accelerated Approvals

 
• By Sue Sutter
  
Runway
The runway is long for the aducanumab confirmatory trial. • Source: Alamy

More from Clinical Trials

More from R&D